Morphine Completed Phase 3 Trials for Neonatal Opioid Withdrawal / Drug withdrawal syndrome neonatal Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01958476Improving Outcomes in Neonatal Abstinence Syndrome
NCT02810782How to Treat Opiate Withdrawal in Neonates
NCT01452789Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome